Seung Ho Ji

Seung Ho Ji is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of obesity treatment. His innovative work focuses on developing effective solutions for lipolysis, which is the breakdown of fats.

Latest Patents

Seung Ho Ji holds a patent for a lipolytic composition containing phosphocholine derivatives. This invention provides a pharmaceutical composition aimed at preventing or treating obesity, specifically targeting localized fat deposits. The composition includes certain phosphocholine derivatives or their pharmaceutically acceptable salts. It demonstrates excellent lipolytic activity and uniformity, while also minimizing side effects such as inflammation and tissue necrosis at the site of administration. Furthermore, the composition boasts excellent storage stability, making it a promising option in the pharmaceutical market.

Career Highlights

Seung Ho Ji is associated with Penmix Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on obesity treatment and fat management.

Collaborations

Seung Ho Ji collaborates with talented individuals in his field, including Dongkyu Park and Hana Lee. Their combined expertise contributes to the innovative environment at Penmix Ltd.

Conclusion

Seung Ho Ji's contributions to the field of lipolytic compositions highlight his role as an important inventor in the pharmaceutical industry. His innovative approach to treating obesity through effective compositions showcases the potential for advancements in health and wellness.

Profile summary based on public USPTO records.